JNJON

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

NaamJNJON

PositieNo.3383

Marktkapitalisatie$0.00

Volledig verwaterde marktkapitalisatie$0.00

Marktaandeel%

Handelsvolume/marktkapitalisatie (24 uur)1,030,955.86%

Circulerende voorraad101.06412834

Maximale voorraad0

Totale voorraad101.06412834

Circulatiesnelheid%

Uitgiftedatum--

De prijs waartegen het actief voor het eerst werd uitgegeven--

Hoogste prijs ooit250.607309426007,2026-03-02

Laagste prijs203.9667432969526,2026-01-09

Publieke blockchainETH

InleidingJohnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

Sector

Sociale media

• Officiële website
• Blokverkenner

etfindex:mc_etfindex_sourceDisclaimer: De door cmc verstrekte gegevens mogen niet worden beschouwd als beleggingsadvies.